These trials involve tens of thousands of patients
Under such pressure, Novo Nordisk needs to achieve a new breakthrough in oral Semaglutide tablets to break this deadlock
The company now projects flat net sales (versus 2% growth previously), a reported EPS decline of 6% to 9% (versus a decrease of 1% to 3% previously) and a mid-single-digit decline in adjusted EPS (versus a prior forecast of down slightly)
Retatrutide (LY3437943) is a single peptide engineered to agonise three incretin-family receptors at once: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR) 26
In short, the Wegovy pill only works to its full potential when the fasting and timing rules are followed, so taking it correctly makes a real difference to your results
Biochemical Journal 51:12933